UniProt P61626
Lysozyme C (P61626)
Lysozyme C (UniProt P61626), EC 3.2.1.17: 403 experimental structures on GenesisL1, 9 ligands bound, 17 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- P61626
- Protein
- Lysozyme C
- EC
- 3.2.1.17
- Experimental structures
- 403
- Predicted models
- 0
- Ligands
- 9
- Pockets
- 17 · 2 records with a druggable one
Structures
403 records of P61626 in the MolNFT archive: 403 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 133L | Role of arg 115 in the catalytic action of human lysozyme. X-ray structure of his 115 and glu 115… | x-ray diffraction | A | — | — |
| 133L | Role of arg 115 in the catalytic action of human lysozyme. X-ray structure of his 115 and glu 115… | x-ray diffraction | A | — | — |
| 134L | Role of arg 115 in the catalytic action of human lysozyme. X-ray structure of his 115 and glu 115… | x-ray diffraction | A | — | — |
| 134L | Role of arg 115 in the catalytic action of human lysozyme. X-ray structure of his 115 and glu 115… | x-ray diffraction | A | — | — |
| 1B5U | Contribution of hydrogen bonds to the conformational stability of human lysozyme: calorimetry and… | x-ray diffraction | A | — | — |
| 1B5U | Contribution of hydrogen bonds to the conformational stability of human lysozyme: calorimetry and… | x-ray diffraction | A | — | — |
| 1B5V | Contribution of hydrogen bonds to the conformational stability of human lysozyme: calorimetry and… | x-ray diffraction | A | — | — |
| 1B5V | Contribution of hydrogen bonds to the conformational stability of human lysozyme: calorimetry and… | x-ray diffraction | A | — | — |
| 1B5W | Contribution of hydrogen bonds to the conformational stability of human lysozyme: calorimetry and… | x-ray diffraction | A | — | — |
| 1B5W | Contribution of hydrogen bonds to the conformational stability of human lysozyme: calorimetry and… | x-ray diffraction | A | — | — |
| 1B5X | Contribution of hydrogen bonds to the conformational stability of human lysozyme: calorimetry and… | x-ray diffraction | A | — | — |
| 1B5X | Contribution of hydrogen bonds to the conformational stability of human lysozyme: calorimetry and… | x-ray diffraction | A | — | — |
| 1B5Y | Contribution of hydrogen bonds to the conformational stability of human lysozyme: calorimetry and… | x-ray diffraction | A | — | — |
| 1B5Y | Contribution of hydrogen bonds to the conformational stability of human lysozyme: calorimetry and… | x-ray diffraction | A | — | — |
| 1B5Z | Contribution of hydrogen bonds to the conformational stability of human lysozyme: calorimetry and… | x-ray diffraction | A, B | — | — |
| 1B5Z | Contribution of hydrogen bonds to the conformational stability of human lysozyme: calorimetry and… | x-ray diffraction | A, B | — | — |
| 1B7L | Verification of spmp using mutant human lysozymes | x-ray diffraction | A | — | — |
| 1B7L | Verification of spmp using mutant human lysozymes | x-ray diffraction | A | — | — |
| 1B7M | Verification of spmp using mutant human lysozymes | x-ray diffraction | A | — | — |
| 1B7M | Verification of spmp using mutant human lysozymes | x-ray diffraction | A | — | — |
| 1B7N | Verification of spmp using mutant human lysozymes | x-ray diffraction | A | — | — |
| 1B7N | Verification of spmp using mutant human lysozymes | x-ray diffraction | A | — | — |
| 1B7O | Verification of spmp using mutant human lysozymes | x-ray diffraction | A | — | — |
| 1B7O | Verification of spmp using mutant human lysozymes | x-ray diffraction | A | — | — |
| 1B7P | Verification of spmp using mutant human lysozymes | x-ray diffraction | A | — | — |
| 1B7P | Verification of spmp using mutant human lysozymes | x-ray diffraction | A | — | — |
| 1B7Q | Verification of spmp using mutant human lysozymes | x-ray diffraction | A | — | — |
| 1B7Q | Verification of spmp using mutant human lysozymes | x-ray diffraction | A | — | — |
| 1B7R | Verification of spmp using mutant human lysozymes | x-ray diffraction | A | — | — |
| 1B7R | Verification of spmp using mutant human lysozymes | x-ray diffraction | A | — | — |
| 1B7S | Verification of spmp using mutant human lysozymes | x-ray diffraction | A | — | — |
| 1B7S | Verification of spmp using mutant human lysozymes | x-ray diffraction | A | — | — |
| 1BB3 | Human lysozyme mutant A96L | x-ray diffraction | A, B | — | — |
| 1BB3 | Human lysozyme mutant A96L | x-ray diffraction | A, B | — | — |
| 1BB4 | Human lysozyme double mutant A96L, W109H | x-ray diffraction | A, B | — | — |
| 1BB4 | Human lysozyme double mutant A96L, W109H | x-ray diffraction | A, B | — | — |
| 1BB5 | Human lysozyme mutant A96L complexed with chitotriose | x-ray diffraction | A, B | — | — |
| 1BB5 | Human lysozyme mutant A96L complexed with chitotriose | x-ray diffraction | A, B | — | — |
| 1C43 | Mutant human lysozyme with foreign N-terminal residues | x-ray diffraction | A | — | — |
| 1C43 | Mutant human lysozyme with foreign N-terminal residues | x-ray diffraction | A | — | — |
| 1C45 | Mutant human lysozyme with foreign N-terminal residues | x-ray diffraction | A | — | — |
| 1C45 | Mutant human lysozyme with foreign N-terminal residues | x-ray diffraction | A | — | — |
| 1C46 | Mutant human lysozyme with foreign N-terminal residues | x-ray diffraction | A | — | — |
| 1C46 | Mutant human lysozyme with foreign N-terminal residues | x-ray diffraction | A | — | — |
| 1C7P | Crystal structure of mutant human lysozyme with four extra residues (eaea) at the N-terminal | x-ray diffraction | A | — | — |
| 1C7P | Crystal structure of mutant human lysozyme with four extra residues (eaea) at the N-terminal | x-ray diffraction | A | — | — |
| 1CJ6 | T11A mutant human lysozyme | x-ray diffraction | A | — | — |
| 1CJ6 | T11A mutant human lysozyme | x-ray diffraction | A | — | — |
| 1CJ7 | T11V mutant human lysozyme | x-ray diffraction | A | — | — |
| 1CJ7 | T11V mutant human lysozyme | x-ray diffraction | A | — | — |
| 1CJ8 | T40A mutant human lysozyme | x-ray diffraction | A | — | — |
| 1CJ8 | T40A mutant human lysozyme | x-ray diffraction | A | — | — |
| 1CJ9 | T40V mutant human lysozyme | x-ray diffraction | A | — | — |
| 1CJ9 | T40V mutant human lysozyme | x-ray diffraction | A | — | — |
| 1CKC | T43A mutant human lysozyme | x-ray diffraction | A | — | — |
| 1CKC | T43A mutant human lysozyme | x-ray diffraction | A | — | — |
| 1CKD | T43V mutant human lysozyme | x-ray diffraction | A | — | — |
| 1CKD | T43V mutant human lysozyme | x-ray diffraction | A | — | — |
| 1CKF | T52A mutant human lysozyme | x-ray diffraction | A | — | — |
| 1CKF | T52A mutant human lysozyme | x-ray diffraction | A | — | — |
343 records more on the page itself.
Ligands
- CL · Chloride ion · in 6 records
- NA · Sodium ion · in 6 records
- NDG · 2-acetamido-2-deoxy-alpha-D-glucopyranose · in 4 records
- SO4 · Sulfate ion · in 4 records
- GLA · alpha-D-galactopyranose · in 2 records
- GZL · beta-D-galactofuranose · in 2 records
- NO3 · Nitrate ion · in 2 records
- RU · Ruthenium ion · in 2 records
- TVG · propyl beta-D-galactofuranoside · in 2 records
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.